- Home
- IMNM vs SENEA Comparison
IMNM vs SENEA Comparison
Compare IMNM & SENEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- SENEA
- Stock Information
- Founded
- IMNM 2006
- SENEA 1949
- Country
- IMNM United States
- SENEA United States
- Employees
- IMNM N/A
- SENEA N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- SENEA Packaged Foods
- Sector
- IMNM Health Care
- SENEA Consumer Staples
- Exchange
- IMNM Nasdaq
- SENEA Nasdaq
- Market Cap
- IMNM 748.3M
- SENEA 629.3M
- IPO Year
- IMNM 2020
- SENEA N/A
- Fundamental
- Price
- IMNM $8.75
- SENEA $90.29
- Analyst Decision
- IMNM Strong Buy
- SENEA
- Analyst Count
- IMNM 5
- SENEA 0
- Target Price
- IMNM $26.40
- SENEA N/A
- AVG Volume (30 Days)
- IMNM 874.4K
- SENEA 85.0K
- Earning Date
- IMNM 08-11-2025
- SENEA 06-12-2025
- Dividend Yield
- IMNM N/A
- SENEA N/A
- EPS Growth
- IMNM N/A
- SENEA N/A
- EPS
- IMNM N/A
- SENEA 5.90
- Revenue
- IMNM $10,938,000.00
- SENEA $1,578,887,000.00
- Revenue This Year
- IMNM N/A
- SENEA N/A
- Revenue Next Year
- IMNM $349.38
- SENEA N/A
- P/E Ratio
- IMNM N/A
- SENEA $15.30
- Revenue Growth
- IMNM N/A
- SENEA 8.25
- 52 Week Low
- IMNM $5.15
- SENEA $56.36
- 52 Week High
- IMNM $16.81
- SENEA $96.79
- Technical
- Relative Strength Index (RSI)
- IMNM 48.43
- SENEA 47.17
- Support Level
- IMNM $9.02
- SENEA $87.99
- Resistance Level
- IMNM $9.91
- SENEA $94.00
- Average True Range (ATR)
- IMNM 0.55
- SENEA 3.17
- MACD
- IMNM -0.08
- SENEA -0.60
- Stochastic Oscillator
- IMNM 9.37
- SENEA 43.92
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.